Sara Ek is a Professor in Immunotechnology at Lund University. She has a keen interest in translational cancer research and with a specific focus of lymphoid malignancies and patient stratification for improved precision medicine efforts. She is the initiator and director of the SpatialOmics@LU facility in Lund and drive development of omics analyses of spatially resolved molecular data. She is engaged in strategic development of research at Lund University through her engagement in the Lund University Cancer Centre Board and the Faculty of Engineering research board. She is one of the co-founders of Immunovia, a company with a commercially available test, for early and non-invasive detection of pancreatic cancer. She is further heading two EU- MSCA Cofund doctoral/post-doctoral programs, the CanFaster programs, that are dedicated to translation of cancer research into clinically useful innovations.